Deterioration Phenotype Four is advanced diabetes with microvascular vulnerability, especially eye disease risk; in SUSTAIN 6 study, semaglutide was associated with higher rates of diabetic retinopathy complications versus placebo, often discussed in the context of rapid glucose improvement in people with preexisting retinopathy risk.
factualpending
Speaker
Dr. Amin DadgarEvidence Quote
“In SUSTAIN 6 study, semaglutide was associated with higher rates of diabetic retinopathy complications versus placebo.”
Created: 8/12/2026, 6:40:36 PM
Your notes
Loading notes...